consortium in 2019. Since that time, the Lab Owl product has been integrated into ARMI’s Tissue Foundry manufacturing process, and the Lab Owl team has made important contributions to several working groups tasked with solving some of the challenges facing tissue engineering and regenerative medicine manufacturing. These working groups include establishing ARMI’s Workforce Characteristics Charter; the Tissue Maturation and Bioreactor Charter; and the Cell Culture and Harvest Charter.
In Conversation with John Moore, President of Scientific Bioprocessing Inc. (SBI)
Published on :Scientific Bioprocessing Inc. (SBI) is on a mission to help scientists and engineers de-risk drug development through leading-edge technology that improves the efficiency, effectiveness, and reproducibility of cell culture and bioprocessing